后疫情时代,检测需求步入常态化轨道,2024年无疑成为ICL行业的调整与转型关键之年。有分析指出,当前中国ICL市场正加速迈向整合阶段,头部企业凭借深厚的技术壁垒与显著的规模效应,持续巩固市场优势;而中小型实验室在成本控制与服务能力上的短板日益凸显,行业资源不断向头部平台汇聚。这一市场重构趋势,使得像艾迪康控股(09860)这样的ICL头部企业备受市场瞩目。3月31日,中国ICL服务提供商...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.